VivoSeq
Other

Local Infiltration

0

Pipeline Programs

2

Active Trials

1

Companies Involved

Local Infiltration is an early-stage landscape with 0 programs across 1 company. The most active players are Pacira Pharmaceuticals, Inc.

Pipeline Metrics

Competitive Density

10/100

Pipeline Velocity

6/100

Mech. Concentration

N/A

Completion Rate

81/100

Attrition Rate

17/100

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

24

clinical trials

Completed17 · 71%
Terminated3 · 13%
Not yet recruiting1 · 4%
Unknown status1 · 4%
Recruiting1 · 4%
Withdrawn1 · 4%

Trial Activity

24 trials

Combination of Nerve Blocks and Local Infiltration Analgesia in Knee Arthroplasty
Not yet recruiting··Phase 4·NCT07350252·200 enrolled
Page 1 of 2

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)